Culture Watch Update
SEE OTHER BRANDS

Your top news on culture, society and lifestyle

Culture Watch Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Culture Watch Update.

Press releases published on May 27, 2025

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

InterDigital to Present at William Blair 45th Annual Growth Stock Conference

WILMINGTON, Del., May 27, 2025 (GLOBE NEWSWIRE) -- InterDigital, Inc. (Nasdaq: IDCC), a mobile, video and AI technology research and development company, today announced that the company will be presenting at the William Blair 45th Annual Growth Stock …

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

GCL Subsidiary’s Offer for Ban Leong Technologies Declared Unconditional in all Respects

SINGAPORE, May 27, 2025 (GLOBE NEWSWIRE) -- GCL Global Holdings Ltd. (NASDAQ: GCL) (“GCL” or the “Company”) is a leading provider of games and entertainment and the indirect parent company of Epicsoft Asia Pte. Ltd. (the “Offeror”), the bidder seeking to …

FLUENT Corp. to Report First Quarter 2025 Financial Results on May 29, 2025

FLUENT Corp. to Report First Quarter 2025 Financial Results on May 29, 2025

TAMPA, Fla., May 27, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) ("FLUENT" or the "Company"), a national cannabis consumer packaged goods company and retailer, today announced it will report financial results for the first quarter …

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

Candel Therapeutics to Host Investor Conference Call Featuring Expert Clinical Perspectives on CAN-2409 Phase 3 Prostate Cancer Data Following 2025 ASCO Presentation

NEEDHAM, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical-stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, today …

Inseego Selected for Preliminary Inclusion in the Russell 2000® Index

Inseego Selected for Preliminary Inclusion in the Russell 2000® Index

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG) (“Inseego” or the “Company”), a global leader in wireless broadband, including 5G mobile broadband and 5G fixed wireless access (FWA) solutions, today announced it has been selected …

StepStone Group to Present at the Morgan Stanley US Financials Conference

StepStone Group to Present at the Morgan Stanley US Financials Conference

NEW YORK, May 27, 2025 (GLOBE NEWSWIRE) -- StepStone Group Inc. (Nasdaq: STEP) today announced that Scott Hart, CEO, and Mike McCabe, Head of Strategy, are scheduled to present at the Morgan Stanley US Financials Conference on Tuesday, June 10, 2025, at 2: …

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

ARS Pharmaceuticals to Participate in Upcoming Investor Conferences

SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to better protect themselves from allergic reactions that could lead to …

Velani Jewelry Celebrates Guam Loyalty with 41.3% Customer Return Rate

Velani Jewelry Celebrates Guam Loyalty with 41.3% Customer Return Rate

Guam’s top waterproof jewelry brand hits 5,000 customers and a 41.3% return rate, driven by rosary necklaces and milestone gifting. HAGATNA, GUAM, May 27, 2025 /⁨EINPresswire.com⁩/ -- Velani Jewelry, a top-ranked Guam jewelry store known for its …

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

Avalyn Announces Upcoming Presentation on its Lead Program AP01, Inhaled Pirfenidone, for the Treatment of Pulmonary Fibrosis at the European Congress of Rheumatology 2025

CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies for the treatment of life-threatening pulmonary diseases, today announced an upcoming presentation at the …

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.

IBN Announces Latest Episode of The BioMedWire Podcast Featuring Gareth Sheridan, CEO of Nutriband Inc.

AUSTIN, Texas, May 27, 2025 (GLOBE NEWSWIRE) -- via IBN – IBN, a multifaceted communications organization engaged in connecting public companies to the investment community, is pleased to announce the release of the latest episode of The BioMedWire Podcast …

MIMEDX to Participate in Upcoming Investor Conferences

MIMEDX to Participate in Upcoming Investor Conferences

MARIETTA, Ga., May 27, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”) today announced that members of its senior management will participate in the following investor conferences: Craig-Hallum 22nd Annual …

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

Nautilus Biotechnology to Participate in the Goldman Sachs 46th Annual Global Healthcare Conference

SEATTLE, May 27, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule protein analysis platform for quantifying the proteome, today announced the company will be participating in the …

Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025

Gabelli Funds to Host 17th Annual Media & Entertainment Symposium Thursday, June 5, 2025

GREENWICH, Conn., May 27, 2025 (GLOBE NEWSWIRE) -- Gabelli Funds will host its 17th Annual Media …

NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

NeurAxis to Participate in the Lytham Partners Spring 2025 Investor Conference on May 29, 2025

CARMEL, Ind., May 27, 2025 (GLOBE NEWSWIRE) -- NeurAxis, Inc. (“NeurAxis,” or the “Company”) (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults …

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June

NewAmsterdam Pharma to Participate at Upcoming Investor Conferences in June

NAARDEN, the Netherlands and MIAMI, May 27, 2025 (GLOBE NEWSWIRE) -- NewAmsterdam Pharma Company N.V. (Nasdaq: NAMS or “NewAmsterdam” or the “Company”), a late-stage, clinical biopharmaceutical company developing oral, non-statin medicines for patients at …

Days Inns - Canada Strengthens Three-Year Partnership with Food Banks Canada Through “After the Bell” Program

Days Inns - Canada Strengthens Three-Year Partnership with Food Banks Canada Through “After the Bell” Program

Toronto, ON, May 27, 2025 (GLOBE NEWSWIRE) -- Days Inns - Canada proudly extends its meaningful partnership with Food Banks Canada for a third consecutive year, supporting the After the Bell program with a significant donation aimed at tackling childhood …

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

NeuroPace Announces Preliminary Results from One-Year Data in NAUTILUS Study

-- NeuroPace has completed the primary endpoint analysis of the one-year data from the first and only clinical study to evaluate neuromodulation therapy for idiopathic generalized epilepsy -- Study met the 12-week post-implant primary safety endpoint, …

ORYZON to Provide Corporate Progress Updates at Several Events in May-June

ORYZON to Provide Corporate Progress Updates at Several Events in May-June

Foro MedCap 2025 BIO International Convention 2025 Discovery and Development Europe 2025 MADRID and CAMBRIDGE, Mass., May 27, 2025 (GLOBE NEWSWIRE) -- Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a …

Zscaler to Host Innovations Briefing for Investors at Zenith Live 2025

Zscaler to Host Innovations Briefing for Investors at Zenith Live 2025

SAN JOSE, Calif., May 27, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (NASDAQ: ZS), the leader in cloud security, today announced that the company will host an innovations briefing for investors on June 3, 2025. The briefing will take place in Las Vegas, Nevada …

ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC

ORIC® Pharmaceuticals to Present Initial Data from Phase 1b Trial of ORIC-944 in Combination with Androgen Receptor Inhibitors in Patients with mCRPC

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service